Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation

द्वारा Heidel, F., Hochhaus, A.
में प्रकाशित Leukemia (2020)

The concept of treatment-free remission in chronic myeloid leukemia

द्वारा Saußele, S, Richter, J, Hochhaus, A, Mahon, F-X
में प्रकाशित Leukemia (2016)

Dose-dependent severe cutaneous reactions to imatinib

द्वारा Ugurel, S, Hildenbrand, R, Dippel, E, Hochhaus, A, Schadendorf, D
प्रकाशित 2003

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice

द्वारा Nieborowska-Skorska, M, Hoser, G, Hochhaus, A, Stoklosa, T, Skorski, T
प्रकाशित 2013

A Classic Improved: Minor Tweaks Yield Major Benefits in Crayfish Slow-Flexor Preparations

द्वारा Weller, Cynthia, Hochhaus, A. Maren, Wright, T. Michael, Mulloney, Brian
में प्रकाशित J Undergrad Neurosci Educ (2015)

Profiling neurotransmitters in a crustacean neural circuit for locomotion

द्वारा Schneider, Anna C., Seichter, Henriette A., Neupert, Susanne, Hochhaus, A. Maren, Smarandache-Wellmann, Carmen R.
में प्रकाशित PLoS One (2018)

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

द्वारा Ernst, T, Merx, K, Gnad-Vogt, U, Lukan, N, Kripp, M, Schultheis, B, Hochhaus, A, Hofheinz, R-D
प्रकाशित 2007

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

द्वारा Hofheinz, R-D, Willer, A, Weisser, A, Gnad, U, Saussele, S, Kreil, S, Hartmann, J T, Hehlmann, R, Hochhaus, A
प्रकाशित 2004

Phase I Study of INNO-406, a Dual Abl/Lyn Kinase Inhibitor, in Philadelphia Chromosome-Positive Leukemias Post-Imatinib Resistance or Intolerance

द्वारा Kantarjian, H., le Coutre, P., Cortes, J., Pinilla-Ibarz, J., Nagler, A., Hochhaus, A., Kimura, S., Ottmann, O.
प्रकाशित 2010

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer

द्वारा Hofheinz, R-D, Heinemann, V, von Weikersthal, L F, Laubender, R P, Gencer, D, Burkholder, I, Hochhaus, A, Stintzing, S
प्रकाशित 2012

Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?

द्वारा Kälsch, A-I, Soboletzki, M, Schmitt, W H, van der Woude, F J, Hochhaus, A, Yard, B A, Birck, R
प्रकाशित 2008

Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter hyperferritinämischer Inflammation

द्वारा La Rosée, P., Bremer, H.-C., La Rosée, F., Mohm, P., Hochhaus, A., Gehrke, I., Kumle, B., Benzing, A., Russo, S.
में प्रकाशित Med Klin Intensivmed Notfmed (2020)

Erratum zu: Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter Hyperferritinämischer Inflammation

द्वारा La Rosée, P., Bremer, H.-C., La Rosée, F., Mohm, P., Hochhaus, A., Gehrke, I., Kumle, B., Benzing, A., Russo, S.
में प्रकाशित Med Klin Intensivmed Notfmed (2020)

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

द्वारा Hofheinz, R-D, Hartmann, J T, Willer, A, Oechsle, K, Hartung, G, Gnad, U, Saussele, S, Kreil, S, Bokemeyer, C, Hehlmann, R, Hochhaus, A
प्रकाशित 2004

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

द्वारा Willeke, F, Horisberger, K, Kraus-Tiefenbacher, U, Wenz, F, Leitner, A, Hochhaus, A, Grobholz, R, Willer, A, Kähler, G, Post, S, Hofheinz, R-D
प्रकाशित 2007

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research...

द्वारा Steinbild, S, Mross, K, Frost, A, Morant, R, Gillessen, S, Dittrich, C, Strumberg, D, Hochhaus, A, Hanauske, A-R, Edler, L, Burkholder, I, Scheulen, M
प्रकाशित 2007

Lack of clinical efficacy of imatinib in metastatic melanoma

द्वारा Ugurel, S, Hildenbrand, R, Zimpfer, A, La Rosée, P, Paschka, P, Sucker, A, Keikavoussi, P, Becker, J C, Rittgen, W, Hochhaus, A, Schadendorf, D
प्रकाशित 2005

BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase

द्वारा Hughes, T P, Saglio, G, Quintás-Cardama, A, Mauro, M J, Kim, D-W, Lipton, J H, Bradley-Garelik, M B, Ukropec, J, Hochhaus, A
में प्रकाशित Leukemia (2015)

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

द्वारा La Rosée, F., Bremer, H. C., Gehrke, I., Kehr, A., Hochhaus, A., Birndt, S., Fellhauer, M., Henkes, M., Kumle, B., Russo, S. G., La Rosée, P.
में प्रकाशित Leukemia (2020)

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

द्वारा Hoehler, T, von Wichert, G, Schimanski, C, Kanzler, S, Moehler, M H, Hinke, A, Seufferlein, T, Siebler, J, Hochhaus, A, Arnold, D, Hallek, M, Hofheinz, R, Hacker, U T
प्रकाशित 2013